AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China
HONG KONG, Aug 10, 2021 – (ACN Newswire via SEAPRWire.com) – China Biotech Services Holdings Limited (“CH BIOTECH SER ” or “Company”, stock code: 8037.HK) is pleased to announce that Asia Molecular Diagnostic Laboratory (“AMDL”), a subsidiary of the Company,
More